Ischemia-modified albumin (IMA) can be detected in the early stages of myocardial ischemia before the onset of myocardial necrosis, and is the first serum marker for myocardial ischemia to be approved by the United States Food and Drug Administration [6,7]. This evidence concerns the gene ALB and myocardial ischemia.